INTRODUCTION
With the advancement of genetics and molecular biology, the identification of genes related to disease pathogenesis becomes much easier than before. For example, large-scale human genome sequencing and genome-wide association studies (GWAS) help biologists to identify the variations of genomes as well as how these variations may affect genes and pathways. Genetic information of diseases, for example, single nucleotide polymorphisms (SNPs) that are strongly associated with diseases, either located within genes or outside the genes, provides a blueprint for identifying genes and pathways that are underlying genetic mechanisms of diseases.
As demonstrated in Alzheimer's disease and hypertension [1] , two diseases can be related to each other through their shared genes and pathways. Understanding disease relationships provides a global view of human diseasome (defined as the disease relationship network that combines systematically all genetic disorders with a complete list of disease genes association in [2, 3] ), as well as pharmaceutical guidance of renovating old drugs to treat new diseases [4] .
Network biology provides a general framework for disease comparison. Cellular networks, including gene networks, regulation networks, protein interaction networks and phenotype networks have been developed to meet the challenge of complex systems biology. It is well accepted that complex disease is not caused by a single gene, but by a group of genes that either form a protein complex or a perturbed subnetwork in the network of interest [5] . Current GWAS in diseases include the selection of tagging SNPs; locating neighboring genes around SNPs position, and identifying pathways of those genes.
After that, genes or pathways can be compared or aligned among different diseases. For example, Torkamani et al. [6]) analyzed SNPs that have been identified to be strongly associated with seven diseases and identified common genes that are shared by the diseases in the hope of finding overlapping pathways between diseases [7] . Li and Argarwal [8] mined the medical literature to find shared pathways between diseases. Our previous methods of identifying shared proteins from the WTCCC data of 500,000 SNPs in seven common diseases are also proved to be useful in elucidating disease relationships [9] .
In this paper, we conduct a large-scale disease comparison study by collecting all available GWAS data. Current SNP tagging and selection algorithm are effective in selecting the candidate representative SNPs for chromosomal regions that are in strong linkage disequilibrium (LD). However, the performance of tagged SNPs can be overestimated and as a result, current GWAS analysis might miss the important neighboring SNPs that are in fact contributing to disease pathogenesis [10] . For example, the two tagged SNPs around 978-1-4244-4713-8/10/$25.00 ©2010 IEEE dynein 1 heavy chain 1 gene (Dync1h1) in a case-control study of a northern European derived population have no association with motor neuron degeneration (MND) whereas Dync1h1 has been experimentally proven to be associated with MND [11] , suggesting that the actual causal SNPs may have been missed during the SNP tagging/selection process. In this paper, we address this problem based on the fact that the actual causal disease variants or SNPs might be in strong linkage disequilibrium with the tagged SNPs that have been identified to be associated with the diseases, and we can use linkage disequilibrium to fish out the possible missing genetic variants.
Moreover, instead of doing SNP-wise comparison between each pair of disease, we do network-wise comparison between disease pairs, that is, we consider the putative perturbed subnetworks that lie within those SNPs and compare all the proteins in the subnetworks. Our method can discover potential relations between diseases that are often ignored by single disease SNPs data alone.
II. METHODS

A. Convert SNPs to Genes
We has been suggested previously due to the observation that it is about 30kbp upstream region of target genes, which is enriched with regulatory elements [13] . We then converted all the SNPs of each disease to genes/proteins based on the simple requirement that the SNPs must fall within the genes, regardless of whether the SNPs are in coding or non-coding regions. This straightforward conversion of SNPs to genes might be somewhat conservative as the SNPs that are associated with the diseases may contribute to the diseases by influencing not the host genes in which they reside, but the genes that are either further downstream or upstream of the host genes.
B. Locate Putative Perturbed Subnetworks in Each Disease
We are interested in knowing how genes that harbor are included, making the result hard to interpret [14, 15] ; Second, perturbed subnetworks will grow too dense to allow for any meaningful interpretation of biological networks [15] .
The subnetworks formed by the seed and prey proteins are thus the candidate of perturbed subnetworks in the diseases that may explain what part of the network is affected in the diseases.
C. Measure Disease Similarity Using the Jaccard Index and GO Term Ic Scores
We are interested in constructing a disease relationship network (DRN) where the nodes are diseases and the edge weights indicated the degree of similarity between diseases.
DRN can therefore provide us information on how various diseases are related to one another and a global view on disease similarities. Depending on the specific measurements used for edge weights, we expect that the resulting DRN can provide insight into different perspectives of disease relationships. Here we constructed DRN using two weight schemes. One is the Jaccard Index, defined as the size of intersection divided by the size of union of two sets, which is commonly used to measure the degree of similarity between two sets. Specifically, in the disease case, the Jaccard index between two diseases is calculated by the number of shared genes divided by the total number of unique genes involved in the diseases. Therefore, the higher the Jaccard index is, the higher genetic similarity two diseases show. We calculated the Jaccard index for all pairwise comparisons of the 49 diseases and constructed a DRN. The other is the GO term IC (information content) score, introduced in [16, 17] to measure the semantic similarity in taxonomy. The informativeness of the lowest common ancestor between GO terms can be used as a measurement of semantic similarity, sResnik(Ti, Tj) = ICcorpus(Tlcta), where Tlcta denotes the lowest common taxonomic ancestor between ontological terms Ti and Tj. Each disease can be expressed as a collection of GO terms, and the more similar between the sets of GO terms, the more functional similarity the two diseases share. For the 49 diseases, there are many GO terms derived from the proteins that are likely to be associated with the diseases. However, our observation suggests that some GO terms are more relevant to the diseases than others and thus might dictate more the functional implications of disease phenotypes. Therefore, to better quantify the functional similarity between diseases, we should choose and compare those GO terms that are more close to the diseases than other ones that are not. The goal is to select the top ten most frequently occurred GO terms as the representative GO terms for each disease and calculate IC scores using Resnik's values [17] . To achieve this, we clustered all terms using heuristic fuzzy partition algorithm developed from DAVID package [18] ; If cluster number is greater than ten, for the first ten clusters, we chose the ten highest kappa value GO terms, else we chose (EASE score/total EASE score of all clusters)*10 GO terms for each cluster. Once the ten GO terms is selected, we compared the IC scores using Resnik's method [17] for all pairwise ten GO terms of each disease with another disease, and used the average IC scores as the final measurements of GO term-term similarities between each pair of diseases. In summary, the two measurements of edge weights in the disease relation network complement each other and provide different perspectives for disease relationships. The disease relation network using GO term similarity score as edge weights focuses more on the function perspective of diseases, whereas the one using the extent of shared genes/proteins between diseases focuses more on the genetic perspective.
D. Network Clustering Methods
We used the Restricted Neighborhood Search Clustering (RNSC) method developed by Andrew et al. [19] 
III. RESULTS AND DISCUSSIONS
A. Numbers of SNPs and Genes Associated with Diseases
We compiled SNPs of 49 diseases/phenotypes from the open access database of genome-wide association results curated by Andrew et .al [12] . . Table 1 shows the number of We used the SNP functional annotation portal to get additional SNPs (prey SNPs) that are strongly linked to the set of SNPs (seed SNPs) that we compiled for the 49 diseases.
Using the LD criterion, all the RefSNPs that are in strong linkage disequilibrium with the seed SNPs (i.e., 0.9<r2<1.0)
were obtained. Altogether, we were able to obtain additional number of SNPs for all the diseases, and the total number of SNPs for each disease is shown in Table 1.
All the SNPs were then converted to genes based on the simple criterion that they must fall within genes, regardless of whether the SNPs are in coding or noncoding regions. Table 1 shows the number of genes that are likely to be associated with each of the 49 diseases.
B. Degree of Similarity between Diseases
We observed that for the number of shared SNPs (i.e. the SNPs that have been identified to be associated with both diseases of interest) between 49 diseases, many values are zero Table 2 Table 3 shows the number of shared PPI proteins (i.e. proteins within perturbation subnetworks shared by two diseases) that there are rarely zero shared proteins between each disease pair, so we can more easily compare the difference of disease pair without null value. Moreover, the number of shared PPI proteins is highly correlated to the previous two measurements (Supplement Table 5 ). For example, "Alzheimer's disease"(ad)
and "Triglycerides"(tg) shared 186 proteins in Supplement Table 2 , which is the highest among all diseases pairs with ad and they also shared 2028 proteins in Supplement Table 3, which is also the highest. Some great differences in the number of shared proteins in Supplement Table 2 between disease pairs are not so obvious in Supplement Table 3 . For example, in Supplement Table 2 , "Alzheimer's disease"(ad) and "Brain aging"(ba) share eight proteins and "Alzheimer's disease" and "breast cancer"(bc) share five proteins, so from the perspective of shared proteins, "ad" and "ba" have similar degree of similarity to "ad and "bc". In Supplement Table 3 , "ad" and "ba" share 632 proteins, whereas "ad" and "bc" only 60 proteins. Table 2 shows disease pairs with top ten ranked Jaccard indexes and the number of shared proteins (see supplementary   table 4 for the complete results).
C. Disease Relationship Networks
We built DRNs using two measurements for edge weights, one is the Jaccard index ( Figure 1 ) and the other is GO term IC scores ( Figure 2 ). In these networks, each node represents a disease and each edge the degree of similarity measured by either the Jaccard index or GO term IC scores for the relationship between disease pairs. .Disease relationship measured by the Jaccard index is only weakly correlated with that based on functional similarity (Pearson correlation coefficient: 0.2157, p-value >0.05) .
Intuitively, if two diseases are similar enough in terms of shared genes, it is expected that they also have high degree of functional similarity regarding to their corresponding protein functions within "perturbation subnetwork". Our result shows that this is not necessarily the case. For those disease pairs that have high Jaccard index, their "between GO scores" is not necessarily high. This seems to be contradictive to the recent study of Mehan et.al. [20] , in which nearly all genes within "phenotype-specific modules" are homogeneous in functions.
However, there are two reasons that can explain the difference. 
D. Clustering Disease into Groups
From the disease relationship networks, it is clear that some diseases are more related than others. It is therefore interesting to see whether we can cluster them into groups based on the degree of similarity among diseases. We used RNSC clustering methods as basis for clustering disease network. We limited the node per edge to one, two, and three cutoff respectively, and produce three networks. The first one is made up with 49 highest ranked Jaccard index edges; the second one 98, and the third one 147. Then the RNSC was employed to identify potential clusters with disease similarity. The detailed clustering result is shown in Supplement Table 7 ). Also, using Sle as the query disease, we found that cad is appear in the list of 25 most similar disease list, which indicates that Sle and cad are phenotypically connected (Supplement Table 8 ) . Thus, at least for the two small clusters, there is independent literature support for their relationships. We noted that t1d and t2d belong to the same cluster. It is unclear why they are clustered together. We found that these two diseases have a large number of proteins, which may cause bias and increase the likelihood of them sharing genes and proteins, regardless of whether they are indeed related or not .
IV. CONCLUSION
In a recent study, Mehan et. al. [20] presented an integrative network approach for the study of similarity of phenotypes. Our method is comparable with their studies. However, instead of exploring the microarray data for each phenotype, we used genetic information gathered from GWA studies, or SNP set for each interesting disease or phenotype. We intend to identify the genetic basis of disease relationships rather than based on expression state and environment fluctuation similarity between diseases that is essentially another dimension. It is in this aspect, we conclude, that the degree of similarity between disease pairs in our studies is based uniformly on genetic information. Future work will focus on validating our results using possibly microarray gene expression data and see how the disease relationship networks compare to one another. 
